SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gene therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote ()7/17/1999 3:32:00 PM
From: Mike McFarland   of 319
 
AAV: Does anybody on the thread own Cell Genesys?
I've brought CEGE up a handful of times here and
have often thought this might be one to snag.

They have a phase II going with Hoechst:
autologous genetically modified anti-HIV killer T cell

cellgenesys.com

So many times over the last couple months I've thought
of grabbing some of this--but there is a ceiling on
the stock around $5, amazing resistence there. Also,
with ABGX up strong last week--and no movement on CEGE,
my thought is that the market does not like this at
the moment--no matter how hard BBRS pounds the table.

Any thoughts? And in what catagory would you put this,
I'll call it genetically modified adoptive immunotherapy,
but don't worry, I wont start another folder.

Say Rick...saw the KDUS Soros thing via that website
you liked so much...was he increasing or decreasing
his holdings in that?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News